Effect of Dose and Infusion Time on the Delivery of p-boronophenylalanine for Neutron Capture Therapy |
| |
Authors: | Joel Darrel D Coderre Jeffrey A Micca Peggy L Nawrocky Marta M |
| |
Institution: | (1) Medical Department, Brookhaven National Laboratory, Upton, NY, USA |
| |
Abstract: | Clinical trials of boron neutron capture therapy (BNCT) for glioblastoma multiforme are currently in progress using p-boronophenylalanine (BPA) as the 10B delivery agent. Enhancement of tumor boron uptake and/or the tumor-to-blood (T:B) boron concentration ratio would have the potential of significantly improving the therapeutic gain of BNCT. The effects of total dose, infusion time, and route of administration of BPA on tumor and blood boron concentrations were studied in rats bearing the 9L gliosarcoma. Increasing the total dose of BPA from 250 to 1000mg/kg, administered intravenously over a 2-h infusion period, resulted in an increase in tumor boron concentration from 30 to 70µg 10B/g, with a constant T:B boron concentration ratio of about 3.7:1. Similarly, extension of the infusion time from 2 to 6h, at a constant dose-rate of 125mg BPA/kg/h, resulted in an increase in tumor boron concentration from 30 to 80µg 10B/g, while, again, maintaining a constant T:B ratio of about 3.7:1. In contrast, intracarotid infusion of BPA for 1h at a dose rate of 125mg BPA/kg resulted in an increase in the tumor boron concentration from 26 to 38µg 10B/g with a corresponding increase in the T:B ratio from 3.5:1 to 5.0:1. The effects of these results on the therapeutic gain potentially achievable with BNCT are discussed. |
| |
Keywords: | neutron capture therapy p-boronophenylalanine rat brain tumor 9L gliosarcoma boron concentration biodistribution |
本文献已被 PubMed SpringerLink 等数据库收录! |
|